These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1589405)

  • 21. Paclitaxel-loaded poly(L-lactic acid) microspheres 3: blending low and high molecular weight polymers to control morphology and drug release.
    Liggins RT; Burt HM
    Int J Pharm; 2004 Sep; 282(1-2):61-71. PubMed ID: 15336382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
    Quinten T; De Beer T; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2009 Jan; 71(1):145-54. PubMed ID: 18511248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route.
    Lalla JK; Sapna K
    J Microencapsul; 1993; 10(4):449-60. PubMed ID: 8263674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microencapsulation using poly (L-lactic acid) III: Effect of polymer molecular weight on the microcapsule properties.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(1):41-52. PubMed ID: 2308053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thermal characteristics of poly (DL-lactic acid) microspheres containing neurotensin analogue.
    Yamakawa I; Ashizawa K; Tsuda T; Watanabe S; Hayashi M; Awazu S
    Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2870-2. PubMed ID: 1464121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro protein release and degradation of poly-dl-lactide-poly(ethylene glycol) microspheres with entrapped human serum albumin: quantitative evaluation of the factors involved in protein release phases.
    Li X; Deng X; Huang Z
    Pharm Res; 2001 Jan; 18(1):117-24. PubMed ID: 11336346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microencapsulation using poly(DL-lactic acid). IV: Effect of storage on the microcapsule characteristics.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(3):375-83. PubMed ID: 2384839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual release and molecular mechanism of bilayered aceclofenac tablet using polymer mixture.
    Van Nguyen H; Nguyen VH; Lee BJ
    Int J Pharm; 2016 Dec; 515(1-2):233-244. PubMed ID: 27744034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro study of the properties of bioresorbable lactic acid polymer materials].
    Merloz P; Minfelde R; Schelp C; Lavaste F; Huet-Olivier J; Faure C; Butel J
    Rev Chir Orthop Reparatrice Appar Mot; 1995; 81(5):433-44. PubMed ID: 8560013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of release rate of tetanus vaccine from polyester microspheres.
    Alonso MJ; Cohen S; Park TG; Gupta RK; Siber GR; Langer R
    Pharm Res; 1993 Jul; 10(7):945-53. PubMed ID: 8378256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoscale mechanical measurement determination of the glass transition temperature of poly(lactic acid)/everolimus coated stents in air and dissolution media.
    Wu M; Kleiner L; Tang FW; Hossainy S; Davies MC; Roberts CJ
    Eur J Pharm Sci; 2009 Mar; 36(4-5):493-501. PubMed ID: 19111614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of vitamin E succinate on the stability of polyethylene oxide PEO controlled release matrix tablets.
    Shojaee S; Cumming I; Kaialy W; Nokhodchi A
    Colloids Surf B Biointerfaces; 2013 Nov; 111():486-92. PubMed ID: 23880087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of a Biodegradable Polyesteramide Derived from L-Alanine as Novel Excipient for Controlled Release Matrix Tablets.
    Bonillo Martínez AD; Galán ICR; Bellver MVM
    AAPS PharmSciTech; 2017 Nov; 18(8):3286-3295. PubMed ID: 28589306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microencapsulation using poly(DL-lactic acid). I: Effect of preparative variables on the microcapsule characteristics and release kinetics.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(2):229-44. PubMed ID: 2329448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled release of poly-D,L-lactic acid containing bleomycin.
    Nakamura K; Natsugoe S; Kumanohoso T; Aikou T; Shinkawa T; Yamada K; Fukuzaki H
    Anticancer Drugs; 1995 Jun; 6(3):483-7. PubMed ID: 7545481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of injection moulded matrix tablets based on mixtures of ethylcellulose and low-substituted hydroxypropylcellulose.
    Quinten T; Gonnissen Y; Adriaens E; De Beer T; Cnudde V; Masschaele B; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C
    Eur J Pharm Sci; 2009 Jun; 37(3-4):207-16. PubMed ID: 19491007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of implant tablet for a week-long sustained release.
    Takahashi M; Onishi H; Machida Y
    J Control Release; 2004 Nov; 100(1):63-74. PubMed ID: 15491811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
    Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
    Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preparation of oral sustained-action preparations with a base of biologically degradable polymers. 2. Preparation of matrix tablets with a base of polylactic acid].
    Mank R; Kala H; Richter M
    Pharmazie; 1989 May; 44(5):328-30. PubMed ID: 2772012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A bioresorbable, polylactide reservoir for diffusional and osmotically controlled drug delivery.
    Jonnalagadda S; Robinson DH
    AAPS PharmSciTech; 2000 Oct; 1(4):E29. PubMed ID: 14727894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.